Cerebrolysin is a nootropic drug...
Cerebrolysin is a nootropic drug which contains low molecular biologically active neuropeptides, which penetrate through blood-brain barrier and act directly on the nerve cells.
0 Item Items
This product is no longer in stock
Warning: Last items in stock!
By buying this product you can collect up to 3 loyalty points. Your cart will total 3 loyalty points that can be converted into a voucher of $0.60.
Cerebrolysin is a nootropic drug which contains low molecular biologically active neuropeptides, which penetrate through blood-brain barrier and act directly on the nerve cells. The drug possesses a multimodal organo-specific effect on the brain, provides metabolic regulation, neuroprotection, functional neuromodulation, and neurotrophic activity as well.
Metabolic regulation: Cerebrolysin improves the efficiency of aerobic energy metabolism in the brain, improves the intracellular protein synthesis in the developing and aging brain.
Neuroprotective effect: Cerebrolysin protects neurons (brain nerve cells) from the damaging effects of lactic acidosis, prevents the formation of free radicals, increases survival and prevents neuronal death during hypoxia and ischemia, reduces the damaging neurotoxic effect of certain amino acids (glutamate).
Neurotrophic activity: Cerebrolysin is the only peptide containing nootropic drug with proven neurotrophic activity similar to the action of a neuronal growth factor (NGF).
Functional neuromodulation: the medication possesses a positive effects in patients with cognitive impairment, for concentration improvement and memory problems.
Cerebrolysin has a complex composition which contains a mixture of biologically active oligopeptides which exert poly-functional action. Finally this does not allow to carry a Pharmacokinetic analysis of individual components.
Cerebrolysin is prescribed in the following conditions:
The drug is used parenterally. The dose of duration of treatment depends on the disease you treat and severity of the disease, patients. The medication is used as intravenous and intramuscular injections which should be made only by a medical staff. If you need the recommended doses of the medicine consult our customer support. Any medication information available on the website or provided by our customer support is for informational purposes only.
In excessively rapid injections: in cases rare the medication may cause feeling the heat, sweating, dizziness, tachycardia or fibrillation.
Note that some Cerebrolysin side effects (agitation, hypertension, hypotension, lethargy, tremors, depression, apathy, dizziness, headache, shortness of breath, diarrhea, nausea) were identified during clinical trials and occurred equally in patients, receiving Cerebrolysin , and patients taking placebo.
The medication should be used with caution in I trimester of pregnancy and during breastfeeding. The application of medicines during pregnancy and breastfeeding is possible only in case when the estimated benefit for mother overweighs potential risk for the fetus. There were no conducted clinical studies which could determine negative effects of Cerebrolysin for the fetus.
The medication is contraindicated in patients with acute renal failure.
In excessively rapid implementation of injections a patient may develop fever, sweating, dizziness. Therefore, the drug should be administered slowly.
The medication can be used along with the following standard solutions for infusion: 0.9% sodium chloride, Ringer's solution, 5% solution of dextrose (glucose).
The medication can simultaneously be used Cerebrolysin ® with vitamins and drugs, improving blood circulation. However these drugs should not be mixed in one syringe with Cerebrolysin ®. You should use only the clear solution of the medication .
Clinical trials have shown that Cerebrolysin ® does not affect the ability to drive vehicles and use machinery.
There are no reported any cases of overdose side effects caused by this medication. Do not exceed the recommended dose.
Cerebrolysin may enhance the effects of antidepressants and MAO inhibitors in concomitant use. The drug is not compatible with lipid containing solution and solutions which change pH. The medication should not be mixed with aminoacids solution.
The preparation should be stored out of reach of children, protected from light place at temperature not more than 25°C. Expiration date is 5 years (for vials) and 4 years (for flasks).
No customer questions for the moment.